Celebrating National Nonprofit Day with Our Partners
Every day, nonprofit organizations work on the most stubborn problems in global health. Patient advocacy groups, disease foundations, and community alliances push for better treatments and support families facing devastating diagnoses. August 17 marks National Nonprofit Day and Critical Path Institute is celebrating the impact of these organizations, along with the recognition that our work in regulatory science moves forward because our nonprofit partners make it possible.
Supporting the organizations closest to patients
Behind every breakthrough in medical research stands a dedicated team of advocates and foundation leaders. Those same mission-driven organizations frequently face daunting technical hurdles when trying to organize complex clinical data or navigate regulatory pathways. C-Path exists to bridge that gap. Through collaborative public-private partnerships, we offer secure data-sharing environments, quantitative modeling expertise, and the regulatory frameworks required to turn initial research into approved therapies.
Neutral ground, shared data
Meaningful medical progress requires bringing diverse minds together. Collaboration means scientists from rival pharmaceutical companies, academic researchers, and patient advocates sharing data for the common good. For more than twenty years, C-Path has acted as a neutral convener to make that possible. Partnering with organizations such as the Michael J. Fox Foundation or Parent Project Muscular Dystrophy changes how science operates. When patient advocates share direct insights about living with a condition, researchers adjust how clinical trials measure success. A biological marker means very little if an individual still struggles to complete basic daily tasks.
Turning lived experience into clinical evidence
Translating lived experience into clinical targets requires significant logistical effort behind the scenes. Foundation teams build patient registries from scratch. Community organizers rally families across continents to participate in complex studies. C-Path takes that momentum and builds the standardized tools regulators need to evaluate new medical products safely. Sharing information pre-competitively eliminates redundant effort and saves years of research time across therapeutic areas including rare pediatric diseases and complex neurological conditions.
Six examples of that infrastructure:
- Secure environments where patient-level data can be shared under terms that protect every contributor
- Quantitative disease progression models built from pooled natural history and trial data
- Clinical trial simulation tools that help sponsors size and design studies
- Outcome measures developed with input from the people living with the condition
- Regulatory strategy for submissions that smaller foundational staff may have no realistic way to assemble alone
- Data standards that allow separate research efforts speak to one another
- Our commitment to our partners
Collaborating with advocacy groups goes beyond building secure databases. C-Path invests in the long-term success of every collaborator. More than twenty active consortia operate under our umbrella, each working on specific drug development bottlenecks. Those consortia and programs bring together more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations, and biopharmaceutical companies. Foundation leaders provide the human context, and C-Path provides the scientific infrastructure. The combined approach gets innovation to patients faster and more safely.
Honoring the work behind the science
Nonprofits shape a healthier future for everyone. This National Nonprofit Day, C-Path honors the work of our partners. We invite everyone to explore the groups driving change across the medical landscape at c-path.org.
